Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 18:20:40 - browse：97264

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Pharmacists can make shortage drugs, but at what cost?

WSS

Obesity drugs seen as possible treatment for liver disease MASH

Studies point to risks of excluding people with obesity from drug trials

Why palliative psychiatry is worth discussing

Impact of Dobbs ruling felt at reproductive medicine meeting

FDA gives detailed accounting of AI

Ed Silverman on new gene therapies, biosimilars, coffee, and more

explore

Wikipedia

explore

Tori Bowie and the unacceptable rates of Black maternal death

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Drug repurposing or repositioning? The language matters

How climate

Supreme Court strikes down use of affirmative action

Studies point to risks of excluding people with obesity from drug trials

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Alabama frozen embryo ruling has major implications for IVF clinics

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

focus

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

STAT Summit: Biotech founders on deal

He's a Nobel laureate. Critics say he was misleading on Covid

6 phony surgeries that take placebo to the extreme

STAT Readout Newsletter: Today's biggest biotech updates

Researchers explore possible ties between long Covid, menopause

Wikipedia

explore

knowledge

focus